Source: Annual Congress 2012 - Novel mechanisms of acute lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Alam, Z. Li, S. Janciauskiene, R. Mahadeva (United Kingdom; Hannover, Germany). Z antitrypsin polymerization is associated with enhanced pulmonary inflammation. Eur Respir J 2012; 40: Suppl. 56, 4320

Member's Comments

No comment yet.

Related content which might interest you: Ventilation inhomogeneity is correlated with biomarkers of parenchymal destruction in alpha1 antitrypsin deficiency Source: Eur Respir J 2007; 30: Suppl. 51, 620s Year: 2007 Prevalence of mutations in the alpha 1 antitrypsin gene in patients with pulmonary emphysema Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Neutrophil inflammation of large airways in alpha 1-antityrpsin deficiency Source: Eur Respir J 2002; 20: Suppl. 38, 282s Year: 2002 Variability of sputum inflammatory mediators in COPD and ?1-antitrypsin deficiency}, Source: Eur Respir J 2012; 40: 561-569 Year: 2012 Intra-epithelial polymerization, accumulation and secretion of alpha1 antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Epithelial cell biology Year: 2010 Oxidative stress in TGF-β1-mediated fibrosis in Z alpha-1 antitrypsin cells Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease. Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights Source: Eur Respir J 2009; 33: 475-488 Year: 2009 A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2012; 40: 1475-1482 Year: 2012 Alpha-1 antitrypsin protects protein phospholipid transfer protein from cleavage to counter lung inflammatory responses Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Unfolding the mechanisms of progression of pulmonary emphysema in COPD}, Source: Eur Respir J 2012; 40: 801-803 Year: 2012 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Inhibition of airway proteases in cystic fibrosis lung disease Source: Eur Respir J 2008; 32: 783-795 Year: 2008 Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury Source: Eur Respir J 2008; 31: 633-644 Year: 2008 Short-term variability of biomakers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004 Platelet aggregation status in chronic obstructive pulmonary disease associated with SARS-Cov-19 Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009